2nd Edition of International Cancer & Immuno-Oncology Conference
March 19-21, 2026 | Singapore
Sebaceous Cell Carcinoma
Sebaceous cell carcinoma (SCC) is a rare and aggressive form of skin cancer originating in the sebaceous glands. Although it represents only a small fraction of skin malignancies, its tendency to metastasize makes it a significant health concern. Research on SCC primarily focuses on early detection methods and effective treatments to improve patient outcomes. Recent advancements in genomic analysis have shed light on the genetic mutations driving SCC development, paving the way for targeted therapies. Additionally, immunotherapies and photodynamic therapy are being explored as promising treatment modalities. Collaborative efforts among clinicians, researchers, and pharmaceutical companies aim to unravel the complexities of SCC biology and develop personalized treatment approaches for better management of this challenging disease.
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Allen Chen
Olympic Medical Center, United States
Shilpa S Dhar
UT MD Anderson Cancer Center, United States
Ritu Khanna
University of Manchester, United KingdomSubmit your abstract Today
Title : A novel blood-based mRNA genomics technology for cancer diagnosis and treatment
Rajvir Dahiya, University of California San Francisco, United States
Title : tRNA-derived fragment 3′tRF-AlaAGC modulates cell chemoresistance and M2 macrophage polarization via binding to TRADD in breast cancer
Feng Yan, The Affiliated Cancer Hospital of Nanjing Medical University, China
Title : Integrating single-cell and spatial transcriptomics to uncover and elucidate GP73-mediated pro-angiogenic regulatory networks in hepatocellular carcinoma
Jiazhou Ye, Guangxi Medical University Cancer Hospital, China
Title : Unveiling the synergism of radiofrequency therapy and graphene nanocomposite in tumor cell viability assay
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Analysis of the dynamic evolution and influencing factors of nutritional risk in breast cancer patients during treatment
Jingwen Yan, Sun Yat-sen University, China
Title : Integrative multi-omics reveals metabolic–stemness coupling and novel therapeutic targets in osteosarcoma chemoresistance
Jinyan Feng, Tianjin Medical University Cancer Institute and Hospital, China